Shenzhen YHLO Biotech (SH:688575) 智通财经网·2026-02-06 12:41Group 1 - Heng Rui Medicine's HRS-4642 injection has been included in the list of breakthrough therapeutic varieties, aimed at treating advanced or metastatic pancreatic cancer with KRAS G12D mutation in combination with gemcitabine and albumin-bound paclitaxel, with a total R&D investment of approximately 254 million yuan [1] - Fenglong Co. announced a significant stock price increase of 491.97% from December 25, 2025, to February 5, 2026, and may apply for a trading suspension if prices continue to rise abnormally [2] - Aier Eye Hospital clarified that the reported Xiangyang Hengtai Kang is not affiliated with the company, but is a joint venture established by Aier Medical Investment Group and other investors [3] Group 2 - XWANDA's subsidiary reached a settlement with Weir Electric, which is expected to impact the company's net profit attributable to shareholders by 500 million to 800 million yuan in 2025 [4] - Tianzhong Precision Machine received a lawsuit from eight creditors of its former subsidiary, involving a claim of 108 million yuan [5] - Dongtian Micro plans to invest 400 million yuan to establish a global R&D center and manufacturing headquarters in Dongguan, focusing on precision optical components for optical communication [6] Group 3 - Lvtong Technology's industrial fund plans to invest 10 million yuan in Shenghao Optoelectronics, which specializes in testing equipment for optical communication chips [7] - Tiansheng New Materials has been investigated by the China Securities Regulatory Commission for suspected violations of information disclosure laws [8] - Yahui Long has been placed under investigation by the CSRC for suspected information disclosure violations [9] Group 4 - Longyun Co. plans to acquire 58% of Yuheng Film Industry through a share issuance, with the target company's valuation estimated between 450 million and 530 million yuan [10] - Hu Silicon Industry announced that the National Integrated Circuit Industry Investment Fund plans to reduce its stake by up to 3% [11] - Perfect World reported that its actual controller has reduced his stake by 1.70% through various transactions [12] Group 5 - Sanfu Co. announced that its shareholder, Tangshan Yuanheng Technology Co., intends to reduce its stake by up to 3% [13] - Wanshan Expressway plans to invest 5.42 billion yuan in the expansion of the G30 Lianhuo Expressway in Anhui [14] - New Hope reported sales of 1.1218 million pigs in January, generating revenue of 1.628 billion yuan [15]